Sustainability Report

Overview

The report describes Indofarma's 2021 transformation toward digital healthcare, with drugs, medical devices and herbal products as core segments. It reports 2,901,986,532,879 Rupiah in net sales, 732 consolidated employees, and energy and groundwater-use disclosures. Governance coverage includes Board of Commissioners oversight of sustainability performance, anti-bribery management, and a GRI content index; the company states that no external assurance was obtained.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English, Indonesian
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services